The clinical presentation and treatment outcomes of ocular tuberculosis: a 5-year experience in an endemic area

Int Ophthalmol. 2021 Sep;41(9):3199-3209. doi: 10.1007/s10792-021-01886-y. Epub 2021 May 26.

Abstract

Purpose: To report the clinical presentations of ocular tuberculosis infection (OTB) and the treatment regimen and outcome in an endemic area.

Methods: This is a retrospective case series of patients with presumed OTB treated in a tertiary teaching hospital in Hong Kong in 2014-2019.

Results: Among the nineteen patients recruited, the most common clinical presentation of OTB was retinal vasculitis (42.1%), followed by scleritis, intermediate uveitis, and choroidal tuberculoma (15.8% respectively). 94.7% and 94.4% of the subjects were treated with ATT and steroid, respectively, and 31.6% were put on systemic immunosuppressant prior to the initiation of ATT. Apart from those suffering from intermediate uveitis, most demonstrated good clinical response within 8 weeks of ATT initiation.

Conclusion: Ocular involvement of TB has been increasingly recognized, especially in endemic regions like Hong Kong. High index of suspicion is recommended for OTB in typical clinical phenotypes or recurrent/resistant ocular inflammation unresponsive to conventional therapy. TB retinal vasculitis was the most common presentation of OTB in this study and OTB generally requires treatment with either regional or systemic steroid together with ATT.

Keywords: Anti-tuberculosis treatment; Choroidal tuberculoma; Intermediate uveitis; Ocular tuberculosis; Retinal vasculitis; Scleritis.

MeSH terms

  • Antitubercular Agents / therapeutic use
  • Humans
  • Retrospective Studies
  • Treatment Outcome
  • Tuberculosis, Ocular* / diagnosis
  • Tuberculosis, Ocular* / drug therapy
  • Tuberculosis, Ocular* / epidemiology
  • Uveitis* / diagnosis
  • Uveitis* / drug therapy
  • Uveitis* / epidemiology

Substances

  • Antitubercular Agents